Effects of Treating Depression and Low Perceived Social Support on Clinical Events after Myocardial Infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial

JAMA

Volumn 289, Issue 23, 2003, Pages 3106-3116

  Berkman, Lisa F ^a   Blumenthal, James ^b   Burg, Matthew ^c   Carney, Robert M ^d   Catellier, Diane ^e   Cowan, Marie J ^f   Czajkowski, Susan M ^g   De Busk, Robert ^h   Hosking, James ^e   Jaffe, Allan ⁱ   Kaufmann, Peter G ^g   Mitchell, Pamela ^j   Norman, James ^g   Powell, Lynda H ^k   Raczynski, James M ^l   Schneiderman, Neil ^m  

^a HARVARD UNIVERSITY   (United States)

^b DUKE UNIVERSITY   (United States)

^c YALE UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ MAYO CLINIC   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

^k RUSH UNIVERSITY MEDICAL CENTER   (United States)

^l UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^m UNIVERSITY OF MIAMI   (United States)

ⁿ UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCORING SYSTEM; SOCIAL ISOLATION; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; SURVIVAL; ADAPTIVE BEHAVIOR; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGICAL ASPECT; RISK FACTOR;

ADAPTATION, PSYCHOLOGICAL; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SOCIAL SUPPORT; SURVIVAL ANALYSIS;

EID: 0038507402     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.23.3106     Document Type: Article

References (67)

1. McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors. N Engl J Med. 1996;334:884-890.
2. Berkman LF, Leo-Summers L, Horwitz RI. Emotional support and survival after myocardial infarction: a prospective, population-based study of the elderly. Ann Intern Med. 1992;117:1003-1009.
3. Case RB, Moss AJ, Case N, McDermott M, Eberly S. Living alone after myocardial infarction. JAMA. 1992;267:515-519.
4. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA. 1993;270:1819-1825.
5. Williams RB, Barefoot JC, Califf RM, et al. Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA. 1992;267:520-524.
6. Bush DE, Ziegelstein RC, Tayback M, et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001;88:337-341.
7. Kawachi I, Colditz GA, Ascherio A, et al. A prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA. J Epidemiol Community Health. 1996;50:245-251.
8. Carney RM, Rich MW, TeVelde A, Saini J, Clark K, Jaffe AS. Major depressive disorder in coronary artery disease. Am J Cardiol. 1987;60:1273-1275.
9. Schleifer SJ, Macari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial Infarction. Arch Intern Med. 1989;149:1785-1789.
10. Forrester AW, Lipsey JR, Teitelbaum ML, DePaulo JR, Andrzejewski PL. Depression following myocardial infarction. Int J Psychiatry Med. 1992;22:33-46.
11. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701-709.
12. Frasure-Smith N, Prince R. The ischemic heart disease life stress monitoring program: impact on mortality. Psychosom Med. 1985;47:431-445.
13. Ibrahim MA, Feldman JG, Schultz H, Staiman MJ, Young LJ, Dean D. Management after myocardial infarction: a controlled trial of the effect of group psychotherapy. Int J Psychiatry Med. 1974;5:253-268.
14. Rahe R, O'Neil T, Hagen A, Arthur R. Brief group therapy following myocardial infarction: eighteen month follow-up of a controlled trial. Int J Psychiatry Med. 1975;6:349-358.
15. Rahe R, Ward HW, Hayes V. Brief group therapy in myocardial infarction rehabilitation: three to four-year follow-up of a controlled trial. Psychosom Med. 1979;41:229-242.
16. Dusseldorp E, van Elderen T, Maes S, Meulman J, Kraaij V. A meta-analysis of psychoeducational programs for coronary heart disease patients. Health Psychol. 1999;18:506-519.
17. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease. Arch Intern Med. 1996;156:745-752.
18. Friedman M, Thoresen CE, Gill JJ, et al. Alteration of type A behavior and its effects on cardiac recurrences in post myocardial infarction patients: summary results of the Recurrent Coronary Prevention Project. Am Heart J. 1986;112:653-665.
19. Frasure-Smith N, Lespérance F, Prince RH, et al. Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet. 1997;350:473-479.
20. Jones DA, West RR. Psychological rehabilitation after myocardial infarction: multicenter randomized controlled trial. BMJ. 1996;313:1517-1521.
21. The ENRICHD Investigators. Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. Am Heart J. 2000;139(1 Pt 1):1-9.
22. The Joint European Society of Cardiology/American College of Cardiology. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-969.
23. Freedland KE, Skala JA, Carney RM, et al. The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med. 2002;64:897-905.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association;1994
25. Williams JB. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry. 1988;45:742-747.
26. The ENRICHD Investigators. Enhancing Recovery in Coronary Heart Disease (ENRICHD): baseline characteristics. Am J Cardiol. 2001;88:316-322.
27. Berger VW, Exner DV. Detecting selection bias in randomized clinical trials. Control Clin Trials. 1999;20:319-327.
28. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York, NY: Guilford Press; 1979,
29. Blumenthal JA, Burg MM, Barefoot J, Williams RB, Haney T, Zimer G. Social support, Type A behavior and coronary artery disease. Psychosom Med. 1987;49:331-340.
30. Mendes de Leon CF, DiLillo V, Czajkowski S, et al. Psychosocial characteristics following acute myocardial infarction: the ENRICHD pilot study. J Cardiopulm Rehabil. 2001;21:353-362.
31. American Heart Association. An Active Partnership for the Health of Your Heart. Dallas, Tex: American Heart Association; 1990.
32. Beck J. Cognitive Therapy: Basics and Beyond. New York, NY: Guilford Press; 1995.
33. Robinson LA, Berman JS, Neimeyer RA. Psychotherapy for the treatment of depression: a comprehensive review of controlled outcome research. Psychol Bull. 1990;108:30-49.
34. Dobson KS. A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol. 1989;57:414-419.
35. The ENRICHD Investigators. Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD): study intervention. Psychosom Med. 2001;63:747-755.
36. Crow R, Prineas RJ, Jacobs D, Blackburn H. A new classification system for interim myocardial infarction from serial electrocardiographic changes. Am J Cardiol. 1989;64:454-461.
37. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
38. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson Comorbidity Index with administrative data bases. J Clin Epidemiol. 1996;49:1429-1433.
39. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation. 2001;104:1894-1898.
40. Serebruany VL, Gurbel PA, O'Connor CM. Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res. 2001;43:453-462.
41. Veith RC, Raskind MA, Caldwell JH, Barnes RF, Gumbrecht G, Ritchie JL. Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med. 1982;306:954-959.
42. Strik JJ, Honig A, Lousberg R, et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med. 2000;62:783-789.
43. Roose SP, Laghrissi-Thode F, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA. 1998;279:287-291.
44. Nelson JC, Kennedy JS, Pollock BG, et al. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease. Am J Psychiatry. 1999;156:1024-1028.
45. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327:669-677.
46. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285:1711-1718.
47. Arntz HR, Aggrawal R, Wunderlich W, et al. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). Am J Cardiol. 2000;86:1293-1298.
48. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
49. Sacks FM. Lipid-lowering therapy in acute coronary syndromes. JAMA. 2001;285:1758-1760.
50. Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1998;339:1349-1357.
51. SoRelle R. Cardiovascular news. AMIOVIRT. Circulation. 2000;102:E9050-E9051.
52. Carney RM, Freedland KE, Stein PK, Skala JA, Hoffman P, Jaffe AS. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med. 2000;62:639-647.
53. Laghrissi-Thode F, Wagner WR, Pollock BG, Johnson PC, Finkel MS. Elevated platelet factor 4 and beta-thromoglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry. 1997;42:290-295.
54. Musselman DL, Tome RA, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry. 1996;153:1313-1317.
55. Seeman T, Berkman LF, Blazer D, Rowe JW. Social ties and support and neuroendocrine function: the MacArthur studies of successful aging. Ann Behav Med. 1994;16:95-106.
56. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 1992;149:999-1010.
57. Milani RV, Lavie CJ, Cassidy MM. Effects of cardiac rehabilitation and exercise training programs on depression in patients after major coronary events. Am Heart J. 1996;132:726-732.
58. Spertus JA, McDonell M, Woodman CL, Fihn SD. Association between depression and worse disease-specific functional status in outpatients with coronary artery disease. Am Heart J. 2000;140:105-110.
59. Ormel J, Von Korff M. Synchrony of change in depression and disability. Arch Gen Psychiatry. 2000;57:381-382.
60. Brummet BH, Babyak MA, Barefoot JC, et al. Social support and hostility as predictors of depressive symptoms in cardiac patients one month following hospitalization: a prospective study. Psychosom Med. 1998;60:707-713.
61. Holohan CJ, Holohan CK, Moos RH, Brennan PL. Social context, coping strategies, and depressive symptoms: an expanded model with cardiac patients. J Pers Soc Psychol. 1997;72:918-928.
62. Oxman TE, Hull JG. Social support, depression, and activities of daily living in older heart surgery patients. J Gerontol B Psychol Sci Soc Sci. 1997;52:1-14.
63. Lespérance F, Frasure-Smith N, Juneau M, Theroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med. 2000;160:1354-1360.
64. 8arefoot JC, Helms MJ, Mark DB, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol. 1996;78:613-617.
65. Frasure-Smith N, Lespérance F, Juneau M, Talajic M, Bourassa MG. Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med. 1999;61:26-37.
66. Lespérance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 2002;105:1049-1053.
67. Berkman LF, Syme SL. Social networks, host resistance and mortality: a nine year follow-up study of Alameda County residents. Am J Epidemiol. 1979;109:186-204.